Giuseppe Corona

18PUBLICATIONS
36CO-AUTHORS
Metabolic medicineCancer geneticsPharmaceutical delivery technologiesPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Aug 17, 2026
Enzalutamide-Induced Host Metabolic Reprogramming Is Associated with Treatment Outcomes in Patients with Castration-Resistant Prostate Cancer: A Hypothesis-Generating Study.

|Mar 13, 2025
Novel De Novo BRCA2 Variant in an Early-Onset Ovarian Cancer Reveals a Unique Tumor Evolution Pathway.

Gianmaria Miolo, Giovanni Canil, Maurizio Polano

|May 23, 2024
Quantitative assessment of daratumumab in serum via intact light chain measurement using liquid chromatography-high resolution mass spectrometry: a method suitable for therapeutic drug monitoring.

Giovanni Canil, Gianmaria Miolo, Mariapaola Simula

|May 11, 2024
Null Mismatch Repair Proteins Expression Reveals the Temporal Molecular Events in Lynch Syndrome-Related Cancers.

Gianmaria Miolo, Wally Marus, Angela Buonadonna

|Oct 28, 2023
Prospective, Multicenter Phase II Trial of Non-Pegylated Liposomal Doxorubicin Combined with Ifosfamide in First-Line Treatment of Advanced/Metastatic Soft Tissue Sarcomas.

Angela Buonadonna, Simona Scalone, Davide Lombardi

|Oct 27, 2023
Metabolic Clues to Bile Acid Patterns and Prolonged Survival in Patients with Metastatic Soft-Tissue Sarcoma Treated with Trabectedin.

Gianmaria Miolo, Angela Buonadonna, Simona Scalone

Pageof 3

Frequent Collaborators

8 joint publications

Gianmaria Miolo

6 joint publications

Agostino Steffan

3 joint publications

Angela Buonadonna

2 joint publications

Fabio Puglisi